Placenta accreta spectrum (PAS) is a condition where the placenta attaches too deeply into the uterine wall, causing severe bleeding and complications for the mother. PAS occurs in 1 in 300 to 500 deliveries — a 10-fold increase in the past 50 years. However, more than 50% of cases are not detected before delivery. To address this major issue, we are developing a blood-based diagnostic tool from maternal plasma that to detect PAS early. This tool is critical for safe deliveries, especially in cases without traditional risk factors for PAS.
Placental Accreta Spectrum Diagnostic
Early detection of a life-threatening obstetric complication using blood-based diagnostic tools
Join us as we reimagine women’s health
We’re seeking passionate supporters to help advance our groundbreaking research.
Project Stage
Brigham-Wyss Diagnostics Accelerator
Team
Hope Yu
Thomas McElrath
Join us as we reimagine women’s health
We’re seeking passionate supporters to help advance our groundbreaking research.
Join us as we reimagine women’s health
We’re seeking passionate supporters to help advance our groundbreaking research.